IFPW FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

Christopher Goetz

Phone

7033313700

Tax Period

2025-01-01 to 2025-12-31

IFPW FOUNDATION, founded in 2012, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $417K in total revenue in fiscal year 2025. Revenue surged 57% from the prior year, signaling strong growth momentum. Expenses of $365K left a modest 12% surplus.

Mission

Supports organizations and initiatives that improve the availability of vaccines, medicines and other healthcare products to those in need worldwide through a variety of educational and charitable activities, including those focused on pharmaceutical supply chain improvements.

Program Service Accomplishments

Program 1

Expenses: $287,200 Revenue: $318,950

Provides strategic consultation and implementation support to GAVI Alliance, Global Fund, and other donors for the implementation of an executive leadership program, STEP 2.0 Leadership, which...

Provides strategic consultation and implementation support to GAVI Alliance, Global Fund, and other donors for the implementation of an executive leadership program, STEP 2.0 Leadership, which provides online and face-to-face training to public health supply chain managers and personnel to help them improve efficiency and performance. Courses are focused on donors' priority countries and were offered in sub-Saharan Africa, the Middle East, and Southeast Asia.

Program 2

Expenses: $23,645 Revenue: $0

Supports Fight the Fakes Alliance, a Swiss association, in raising awareness around the issue of counterfeit, falsified, and substandard medicines and the dangers they pose to patients worldwide...

Supports Fight the Fakes Alliance, a Swiss association, in raising awareness around the issue of counterfeit, falsified, and substandard medicines and the dangers they pose to patients worldwide. Financial dues are paid which allows a related organization, International Federation of Pharmaceutical Wholesalers, Inc. (IFPW), to serve on the Executive Board of the association and provide strategic direction to the Alliance's programs and efforts. Dues also support the Secretariat, whose functions are performed by a public affairs agency located in Geneva.

Program 3

Expenses: $0 Revenue: $0

Support the African Pharmaceutical Distribution Association (APDA), based in Morocco, to help this pan-African group realize its potential to serve as a strong platform for information exchanges and the development of the private sector for medicines on the Continent. As it is further established, APDA will advocate for improvements in access to medicines, safer and more secure medicines supply chains, to increase localized manufacturing and for greater public-private partnerships in healthcare systems. IFPW Foundation serves as an Advisor to the APDA Board and its various Committees. It also leverages the experiences and resources of IFPW-member companies that are willing to help strengthen African markets.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $95,900

Program Service Revenue $318,950

Investment Income $885

Other Revenue $1,466

TOTAL REVENUE $417,201

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $310,845

Other Expenses $365,286

TOTAL EXPENSES $365,286

Year-over-Year Comparison

	2025	2024	Change
Revenue	$417,201	$264,956	+0.6%
Expenses	$365,286	$381,627	0.0%
Net Income	$51,915	$-116,671	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Ornella Barra	Trustee	0	Director	$0	$0	$0
Elias Solomon Nader	Trustee	0	Director	$0	$0	$0
Jean Marc Leccia	Chairman	0	Officer Director	$0	$0	$0
Brian Tyler	Trustee	0	Director	$0	$0	$0
John Graham	Vice Chariman	0	Officer Director	$0	$0	$0
John Kallend	President	0	Officer Director	$0	$0	$0
Christopher Goetz	Vice President	10	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$417,201	$365,286	$202,636	$51,915
2024	No data	No data	No data	No data
2023	$212,286	$265,013	$215,865	$-52,727
2022	$169,817	$206,845	$248,550	$-37,028
2021	$247,594	$90,013	$283,992	$157,581
2020	$25,866	$55,295	$310,393	$-29,429